Remdesivir Impurity 5 - Names and Identifiers
Name | Remdesivir impurity2
|
Synonyms | Remdesivir impurity2 Remdesivir Impurity 5 Remdesivir intermediate Remdesivir Tri-o benzyl Nitrile Impurity (2R,3R,4R,5R)-2-(4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZIN-7-YL)-3,4-BIS(BENZYLOXY)-5-((BENZYLOXY)METHYL)T 2-C-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-3,4,6-tris-O-(phenylmethyl)-D-altrononitrile (2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carbonitrile
|
CAS | 1355357-49-1
|
Remdesivir Impurity 5 - Physico-chemical Properties
Molecular Formula | C33H31N5O4
|
Molar Mass | 561.64 |
Density | 1.28±0.1 g/cm3(Predicted) |
pKa | 4.11±0.30(Predicted) |
Remdesivir Impurity 5 - Upstream Downstream Industry
Remdesivir Impurity 5 - Introduction
Remdesivir impurity2 is a compound related to Remdesivir. Its properties include physical properties and chemical properties. Physical properties may include features in terms of color, shape, solubility, etc., while chemical properties may relate to features in terms of reactivity, stability, etc.
The specific use of Remdesivir impurity2 may vary due to its specific nature. Different impurities may be generated during the pharmaceutical process or formed during storage and transportation. These impurities may have an impact on the quality, stability, or efficacy of Remdesivir, so it is important to understand Remdesivir impurity2.
Regarding the preparation of Remdesivir impurity2, as I cannot provide specific laboratory methods or industrial production processes, please refer to the relevant chemical literature or pharmaceutical regulations. The method of preparing Remdesivir impurity2 may involve knowledge and technology in synthetic chemistry, isolation and purification, and analytical techniques.
Regarding the security information of Remdesivir impurity2, because I cannot provide specific data, please consider the following aspects. Impurities are generally undesirable compounds present in pharmaceutical preparations that, at certain concentrations, may have adverse effects on the human body. Therefore, safety evaluation of Remdesivir impurity2 may require the conduct of various toxicology studies, clinical trials, and drug regulatory approvals. In order to ensure the safety and effectiveness of drug use, the relevant drug quality standards and regulations should be strictly followed.
Last Update:2024-04-09 20:49:11